Enter your keyword


Clinical Research for Recent Spinal Cord Injury

SCiStar is a clinical research study evaluating the safety and activity of AST-OPC1 oligodendrocyte progenitor cells, an investigational agent for newly injured people with sensorimotor complete cervical (in the neck) spinal cord injury. The SCiStar study will evaluate three increasing doses of AST-OPC1 administered at a single point in time between 14 and 30 days… READ MORE

Bridging the Gap

Bridging the Gap

Severed motor axons can now be made to cross complete spinal cord injuries and connect to muscle groups below the level of injury in rats. Researchers with the University of California San Diego’s Department of Neurosciences’ Center for Neural Repair detailed their breakthrough in a June 13 article in The Journal of Neuroscience. According to… READ MORE